| 2026-05-30 17:24 | UU:BAYZF | | News Release200 | ASCO 2026: Bayer Shares New Findings for NUBEQA(TM) (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial |
| 2026-05-30 17:24 | UU:BAYRY | | News Release200 | ASCO 2026: Bayer Shares New Findings for NUBEQA(TM) (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial |
| 2026-05-30 14:30 | UU:WHWK | | News Release200 | Whitehawk Therapeutics Presents Real-World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026 |
| 2026-05-30 14:30 | UU:PGEN | | News Release200 | Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years |
| 2026-05-30 14:30 | UU:EIKN | | News Release200 | Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology |
| 2026-05-30 14:15 | UU:BNTX | | News Release200 | Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial |
| 2026-05-30 12:03 | UU:BWLP | | News Release200 | BW LPG Enters Into Agreement for Eight 90'cbm Panamax Newbuildings with Hyundai Heavy Industries |
| 2026-05-30 12:00 | UU:MIRM | | News Release200 | Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026 |
| 2026-05-30 11:15 | UU:MLYS | | News Release200 | Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026) |
| 2026-05-30 10:00 | UU:EXEL | | News Release200 | Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX(TM) (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026 |
| 2026-05-30 08:30 | UU:TEM | | News Release200 | Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community |
| 2026-05-30 08:00 | UU:VCYT | | News Release200 | ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer |
| 2026-05-30 08:00 | UU:TEM | | News Release200 | Tempus Introduces 'Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results |
| 2026-05-30 08:00 | UU:SMMT | | News Release200 | Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026 |
| 2026-05-30 08:00 | UU:REPL | | News Release200 | Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting |
| 2026-05-30 08:00 | UU:PFE | | News Release200 | TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer |
| 2026-05-30 08:00 | UU:MOLN | | News Release200 | Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1 |
| 2026-05-30 08:00 | UU:INCY | | News Release200 | Incyte's Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi(TM)/Minjuvi(TM)) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL |
| 2026-05-30 08:00 | UU:IMTX | | News Release200 | Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting |
| 2026-05-30 08:00 | UU:IMNM | | News Release200 | Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting |
| 2026-05-30 08:00 | UU:GRAL | | News Release200 | GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting |
| 2026-05-30 08:00 | UU:COGT | | News Release200 | Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting |
| 2026-05-30 07:00 | UU:SMXW | | News Release200 | SMX and the Age of Parity: Recycled Plastic Is No Longer a Sustainability Choice-It's an Economic Imperative |
| 2026-05-30 07:00 | UU:SMX | | News Release200 | SMX and the Age of Parity: Recycled Plastic Is No Longer a Sustainability Choice-It's an Economic Imperative |
| 2026-05-30 04:14 | UU:VVIVF | | News Release200 | Replenish Nutrients: Market Has Yet to Price in the H2 2026 Capacity and Licensing Inflection |
| 2026-05-29 22:20 | UU:FCPT | | News Release200 | FCPT Announces Agreement to Acquire up to 102 Mission Pet Health Veterinary Properties for $268 Million |
| 2026-05-29 22:01 | UU:VNTXF | | News Release200 | Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform |
| 2026-05-29 21:18 | UU:FOBIF | | News Release200 | Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings |
| 2026-05-29 20:55 | UU:FUAPF | | News Release200 | Global Compliance Completes Acquisition of Global People's Trust |
| 2026-05-29 20:31 | UU:TGGCF | | News Release200 | Toogood Gold Signs Definitive Agreement for Option to Earn 100% Interest in the Table Mountain Project, Nevada |
| 2026-05-29 20:31 | UU:FTRCF | | News Release200 | The FUTR Corporation Reports Financial Results for Q1 2026 |
| 2026-05-29 20:07 | UU:VPTDF | | News Release200 | Ventripoint Announces Adoption of Semi-Annual Reporting (SAR) |
| 2026-05-29 20:00 | UU:CLPS | | News Release200 | CLPS Incorporation Receives Nasdaq Notification Regarding Minimum Bid Price Requirements |
| 2026-05-29 19:57 | UU:CGMXF | | News Release200 | Canadian Goldfields Appoints Harp Gosal as Director of Capital Markets and Communications |
| 2026-05-29 19:35 | UU:CCMCF | | News Release200 | Core Critical Approved for Listing on OTCQB(R) Venture Market |
| 2026-05-29 19:15 | UU:FCHL | | News Release200 | FCHL Receives Nasdaq Deficiency Notice on May 26, 2026 |
| 2026-05-29 19:10 | UU:ZENO | | Street Wire165 | SEC defendant Csurgo pleads guilty in New York |
| 2026-05-29 19:10 | UU:*SEC | | Street Wire165 | SEC defendant Csurgo pleads guilty in New York |
| 2026-05-29 19:03 | UU:KNXFF | | News Release200 | Vault Strategic Commences Exploration at War Bond Historical Tungsten Mine, Nevada |
| 2026-05-29 19:01 | UU:NHHHF | | News Release200 | FUELPOSITIVE EXTENDS TERM OF SHARE PURCHASE WARRANTS |
| 2026-05-29 18:52 | UU:AISXF | | News Release200 | AISIX Solutions Inc. Provides Status Report of Annual Financial Statements and MD&A |
| 2026-05-29 18:41 | UU:CLGPF | | News Release200 | Clean Seed Capital Announces non-brokered Private Placement |
| 2026-05-29 18:38 | UU:GENRF | | News Release200 | Generation Uranium increases and Closes First Trance of Non-Brokered Private Placement |